Astria Therapeutics (ATXS) Stock Chart & Stock Price History $4.26 +0.30 (+7.58%) As of 05/19/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Astria Therapeutics Stock Price Performance The Astria Therapeutics (ATXS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 55.58%, with a year-to-date return of -52.35%. In the past month, the stock has increased 5.45%, reflecting recent market activity. As of the latest close, Astria Therapeutics traded at $4.26 with a market cap of $240.41 million and volume of 671,346 shares. Five years ago, the stock traded at a split-adjusted price of $37.32, representing a 88.59% decrease over that period. At the time, it had a market cap of $112.05 million and a volume of 81,910 shares. Receive ATXS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Astria Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+6.77%1 Month Performance+5.45%3 Month Performance-37.54%Year-To-Date Performance-52.35%1 Year Performance-55.58%5 Year Performance-88.59% ATXS Stock Chart for Tuesday, May, 20, 2025 ATXS Chart by TradingView Astria Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/19/2025$3.96$4.26+7.58%$4.42$3.84671,346 shs$240.41 million05/16/2025$3.99$3.96-0.75%$4.03$3.92373,273 shs$223.48 million05/15/2025$3.97$3.99+0.50%$4.05$3.75405,539 shs$225.17 million05/14/2025$3.90$3.97+1.79%$4.33$3.69878,151 shs$224.04 million05/13/2025$4.37$3.90-10.76%$4.80$3.82734,089 shs$220.09 million05/12/2025$4.23$4.37+3.31%$4.74$4.30872,027 shs$246.62 million05/09/2025$4.43$4.23-4.60%$4.70$4.13470,953 shs$238.72 million05/08/2025$4.38$4.43+1.21%$4.51$4.21867,919 shs$250.23 million05/07/2025$4.39$4.38-0.09%$4.49$4.25503,080 shs$247.24 million05/06/2025$5.11$4.39-14.19%$5.12$4.33470,697 shs$247.46 million Get the Latest News and Ratings for ATXS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Astria Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/05/2025$5.36$5.11-4.66%$5.36$5.10223,693 shs$288.38 million05/02/2025$5.16$5.36+3.88%$5.47$5.18408,704 shs$302.49 million05/01/2025$5.16$5.16$5.27$5.05951,406 shs$291.20 million04/30/2025$5.12$5.16+0.78%$5.27$5.01361,269 shs$291.20 million04/29/2025$4.96$5.12+3.23%$5.19$5.02327,708 shs$288.94 million04/28/2025$5.17$4.96-4.06%$5.21$4.80363,792 shs$279.91 million04/25/2025$5.21$5.17-0.77%$5.35$4.97292,646 shs$291.76 million04/24/2025$5.19$5.21+0.39%$5.32$5.001.40 million shs$294.02 million04/23/2025$4.62$5.19+12.34%$5.31$4.74860,968 shs$260.73 million04/22/2025$4.11$4.62+12.41%$4.80$4.16855,048 shs$260.73 million04/21/2025$4.04$4.11+1.73%$4.17$3.94450,484 shs$231.94 million Related Companies Collegium Pharmaceutical Stock Chart Syndax Pharmaceuticals Stock Chart Arcus Biosciences Stock Chart Enliven Therapeutics Stock Chart Avadel Pharmaceuticals Stock Chart Spyre Therapeutics Stock Chart Pharvaris Stock Chart Ardelyx Stock Chart Intellia Therapeutics Stock Chart Zymeworks Stock Chart Receive ATXS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Astria Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ATXS) was last updated on 5/20/2025 by MarketBeat.com Staff From Our PartnersHow I profit during chaos…This Guy THRIVES on Chaos Wall Street legend Larry Benedict has thrived through every major market crash. I...Brownstone Research | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredAI Firm Enters America's Largest Medicaid MarketNew York's $95B system just approved a new AI healthcare platform. Here's what to know. A major shift in U....i2i Marketing Group, LLC | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astria Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Astria Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
